Correlation Between Apogee Therapeutics, and Auddia

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Auddia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Auddia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Auddia Inc, you can compare the effects of market volatilities on Apogee Therapeutics, and Auddia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Auddia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Auddia.

Diversification Opportunities for Apogee Therapeutics, and Auddia

0.35

Correlation Coefficient

Apogee Therapeutics,  Auddia

Weak diversification

The 3 months correlation between Apogee and Auddia is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Auddia Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Auddia Inc and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Auddia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Auddia Inc has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Auddia go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Auddia

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 0.29 times more return on investment than Auddia. However, Apogee Therapeutics, Common is 3.43 times less risky than Auddia. It trades about -0.01 of its potential returns per unit of risk. Auddia Inc is currently generating about -0.11 per unit of risk. If you would invest  4,652  in Apogee Therapeutics, Common on September 20, 2024 and sell it today you would lose (183.00) from holding Apogee Therapeutics, Common or give up 3.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	61.9%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Auddia Inc

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Auddia Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Auddia Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Apogee Therapeutics, and Auddia

The main advantage of trading using opposite Apogee Therapeutics, and Auddia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Auddia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auddia will offset losses from the drop in Auddia's long position.

The idea behind Apogee Therapeutics, Common and Auddia Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.